KDA
- Current
- Browse
- Collections
-
For contributors
- For Authors
- Instructions to authors
- Article processing charge
- e-submission
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
- About
- Editorial policy
Search
- Page Path
- HOME > Search
Editorial
- Obesity and Metabolic Syndrome
- Simply the Best: Anthropometric Indices for Predicting Cardiovascular Disease
- Jie-Eun Lee
- Diabetes Metab J. 2019;43(2):156-157. Published online April 15, 2019
- DOI: https://doi.org/10.4093/dmj.2019.0057
- 2,933 View
- 41 Download
- 2 Web of Science
- 1 Crossref
-
PDF
PubReader -
Citations
Citations to this article as recorded by
- Physical performance and glycemic control under SGLT-2-inhibitors in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH): Design of a 4-week prospective observational study
Devine S. Frundi, Eva Kettig, Lena Luise Popp, Melanie Hoffman, Marine Dumartin, Magali Hughes, Edgar Lamy, Yvonne Joko Walburga Fru, Arjola Bano, Taulant Muka, Matthias Wilhelm
Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
- Physical performance and glycemic control under SGLT-2-inhibitors in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH): Design of a 4-week prospective observational study
First
Prev
